High-resolution quantification of specific mRNA levels in human brain autopsies and biopsies

Genome Research

Volumn 10, Issue 8, 2000, Pages 1219-1229

  Castensson, Anja ^a   Emilsson, Lina ^a   Preece, Paul ^b   Jazin, Elena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; MESSENGER RNA; NUCLEASE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; AUTOPSY; BRAIN BIOPSY; BRAIN CORTEX; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; RNA ANALYSIS; TIME;

AGED; BRAIN CHEMISTRY; CEREBRAL CORTEX; FEMALE; GENE EXPRESSION; HUMANS; MALE; POSTMORTEM CHANGES; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 0033828268     PISSN: 10889051     EISSN: None     Source Type: Journal    
DOI: 10.1101/gr.10.8.1219     Document Type: Article

References (58)

1. Pharmacogenomics - It's not just pharmacogenetics
2. Gene expression informatics - It's all in your mind
3. TrkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients: An in situ hybridization study
4. Genes, environment, and personality
5. Mapping genes for human personality
6. The genetics of cancer-a 3D model
7. DNA microarrays in drug discovery and development
8. Use of a cDNA microarray to analyse gene expression patterns in human cancer
9. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia
10. Cluster analysis and display of genome-wide expression patterns
11. Increased expression of mitochondrial genes in human alcoholic brain revealed by differential display
12. Metabolism, pharmacogenetics, and metabolic drug-drug interactions of antipsychotic drugs
13. Statistical methodology: IV. Analysis of variance, analysis of covariance, and multivariate analysis of variance
14. A Novel Method for Real Time Quantitative RT-PCR
15. Postmortem stability of dopamine D1 receptor mRNA and D1 receptors
16. Detecting selective expression of genes and proteins
17. Preferential involvement of excitatory neurons in medial temporal lobe in schizophrenia
18. Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia
19. Real time quantitative PCR
20. Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between alzheimer and normal brain
21. Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease
22. Growth-associated protein (GAP-43), its mRNA, and protein kinase C (PKC) isoenzymes in brain regions of depressed suicides
23. A decrease of reelin expression as a putative vulnerability factor in schizophrenia
24. The transcriptional program in the response of human fibroblasts to serum
25. Genome expression on the world wide web
26. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis
27. Comparative gene-expression analysis
28. Psychiatric genetics: Search for phenotypes
29. Analysis of covariance by the SAS GLM procedure
30. Serotonin receptors and their function in sleep, anxiety disorders and depression
31. Advances in quantitative PCR technology: 5' nuclease assays
32. Serotonergic basis of antipsychotic drug effects in schizophrenia
33. Drug target validation and identification of secondary drug target effects using DNA microarrays
34. Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy patients
35. Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain
36. Update on dopamine receptors
37. NMDA NR1 subunit mRNA and glutamate NMDA-sensitive binding are differentially affected in the striatum and pre-frontal cortex of Parkinson's disease patients
38. GABA(A) receptor alpha1, alpha4, and beta3 subunit mRNA and protein expression in the frontal cortex of human alcoholics
39. The isolation and in vitro translation of undegraded messenger RNAs from human postmortem brain
40. Mediator protein mutations that selectively abolish activated transcription
41. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia
42. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
43. Characterisation of messenger RNA extracted postmortem from the brains of schizophrenic, depressed and control subjects
44. The Genexpress IMAGE Knowledge Base of the Human Brain Transcriptome: A Prototype Integrated Resource for Functional and Computational Genomics
45. Serotonin 5-HT2A receptors: Molecular biology and mechanisms of regulation
46. Identification and cloning of differentially expressed genes
47. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of 'neuroleptic-free' schizophrenics: Evidence on reversible up-regulation by typical neuroleptics
48. Expression of 17beta-hydroxysteroid dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe
49. Expression of CYP19 (aromatase) mRNA in the human temporal lobe
50. The polymerase chain reaction: From functional genomics to high-school practical classes
51. Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease
52. Expression of cytochrome P450RAI (CYP26) in human fetal hepatic and cephalic tissues
53. Theory and practice of psychopharmacogenetics
54. In search of differentially expressed genes and proteins
55. Large-scale temporal gene expression mapping of central nervous system development
56. Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease: Histotopographical correlation with amyloid plaques and hyperphosphorylated-tau protein
57. Some statistical methods for multiple endpoints in clinical trials